Literature DB >> 15695272

Regulatory authorities review use of galantamine in mild cognitive impairment.

Susan Mayor.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15695272      PMCID： PMC548208          DOI： 10.1136/bmj.330.7486.276-b

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  7 in total

1.  When is it dementia?

Authors:  Roy Yaari; Adam S Fleisher; Anna D Burke; Helle Brand; Jan Dougherty; James D Seward; Pierre N Tariot
Journal:  Prim Care Companion CNS Disord       Date:  2011

2.  A tale of 2 amyloid positron emission tomography scans in patients with mild cognitive impairment.

Authors:  Roy Yaari; Adam S Fleisher; James D Seward; Anna D Burke; Helle Brand; Pierre N Tariot
Journal:  Prim Care Companion CNS Disord       Date:  2012-08-30

Review 3.  Novel regimens and delivery systems in the pharmacological treatment of Alzheimer's disease.

Authors:  Nazem Bassil; George T Grossberg
Journal:  CNS Drugs       Date:  2009       Impact factor: 5.749

Review 4.  Treating vascular risk factors and maintaining vascular health: is this the way towards successful cognitive ageing and preventing cognitive decline?

Authors:  K Alagiakrishnan; P McCracken; H Feldman
Journal:  Postgrad Med J       Date:  2006-02       Impact factor: 2.401

Review 5.  Dementia syndromes: evaluation and treatment.

Authors:  Kevin R Scott; Anna M Barrett
Journal:  Expert Rev Neurother       Date:  2007-04       Impact factor: 4.618

Review 6.  Cholinesterase inhibitors in mild cognitive impairment: a systematic review of randomised trials.

Authors:  Roberto Raschetti; Emiliano Albanese; Nicola Vanacore; Marina Maggini
Journal:  PLoS Med       Date:  2007-11-27       Impact factor: 11.069

7.  Changes in cerebral glucose metabolism after 3 weeks of noninvasive electrical stimulation of mild cognitive impairment patients.

Authors:  Kyongsik Yun; In-Uk Song; Yong-An Chung
Journal:  Alzheimers Res Ther       Date:  2016-12-01       Impact factor: 6.982
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.